Radiotherapy of Conjunctival Lymphoma with A Specially Designed Lens Block

許 維中, 丁 禮莉(Lai-Lei Ting), 鄭 秀成, 王 博民, 雷 德, 陳 斯榮, 鍾 娜娜, 林 高德

Research output: Contribution to journalArticlepeer-review


Purpose:To evaluate and discuss the therapeutic results and technique of conjunctival lymphoma. Materials and Methods: This retrospective study was to review the 10 patients with conjunctival lymphoma treated at National Taiwan University Hospital from 1988 to 1996. There were 8 men and 2 women. The range of age was 32 - 75 years old, mean: 59.1 years old. Most of the patients presented with conjunctival mass, reddish eyes and forelgn body sensation. The conjunctival lesions in all patients were treated with a single anterior field which covered the entire conjunctiva, using 3 MeV to 10 MeV electron beam. Total dose of 30 Gy to 50 Gy was delivered in 15 to 25 fractions over 23 to 33 days. In all cases, a specially designed lead shield was used to protect the lens. The follow-up time ranged from 24 months to 124 months.Results: All patients were doing well with no sign of active localized or distant disease till the closing date of the study. Moreover, the complications, including decreased visual acuity, cataract and photophobia, were minimal.Conclusion: Lymphoma clinically localized to conjunctiva as the initial presentation can be cured by radiation therapy with a dosage of 30 Gy to 40 Gy. The complications of radiation therapy can be minimized with sophisticated treatment technique and well protection of the highly radiosensitive lens.
Translated title of the contribution結膜淋巴瘤之放射治療:特殊設計之水晶體合金模塊
Original languageEnglish
Pages (from-to)161-168
Number of pages8
Issue number3
Publication statusPublished - 2000
Externally publishedYes


  • Cunjunctival lymphoma
  • neoplasm
  • Radiotherapy
  • lens


Dive into the research topics of 'Radiotherapy of Conjunctival Lymphoma with A Specially Designed Lens Block'. Together they form a unique fingerprint.

Cite this